Special Startup Series: Fast-tracking healthcare accessibility

Chennai based healthtech startup, LifeSigns has developed an intelligently monitoring biosensor by merging the ideas of semiconductors and chip technology together

0
58
LifeSigns team in Chennai.
Chennai/New Delhi: Most of the time, information about a patient’s vital signs is recorded and evaluated manually when a doctor visits the facility once a day. When a patient’s vital signs enter the danger zone, the issue is escalated and brought to the attention of the doctor on duty.  This procedure provides a narrow window of time to undertake treatments that might save lives.
“That’s when the thought came: what if we could monitor patients, save lives, and create a dashboard that could communicate vitals with medical staff?” mentions Hari Subramanium, Founder and Chief Executive Officer of Chennai based startup, LifeSigns that has developed an intelligently monitoring (iMS) biosensor by merging the ideas of semiconductors and chip technology together.
The LifeSigns iMS biosensor is an intelligent monitoring device that automatically compiles all of the critical information and makes it accessible to the healthcare practitioner to view on a single screen, in real time. This results in fewer mistakes made by humans, more time for personnel to devote to rescuing other people, and lower overall operating expenses. The product is designed for usage in a variety of settings, including hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions.
LifeSigns is an emerging player in wireless monitoring systems for in-hospital and outpatient monitoring. The company utilises biomedical engineering, data analytics, chip design, mobile, and cloud software to develop decision-making paradigms that result in improved health and economic results.
Inception and the broader vision
Hari Subramanium, a seasoned entrepreneur, co-founded LifeSigns along with Shouri Akkineni who comes from a vivid background, with his accomplishments drawing a line across his diverse passions. A Microbiology undergraduate,Shouri’s attempt at IISER veered him to discovering his love for the life sciences.
“The adventure of LifeSigns began in the year 2020, right before the world was devastated by the pandemic, which limited our access to hospitals and physicians in order to test our iMS biosensor. This was one of the most difficult moments for us, and it was also one of the most trying times in history. This barrier continues to exist in the form of making contact with the hospital or receiving an introduction in order to present them with a pilot project idea,” informs Hari.
LifeSigns is assisting doctors and nursing professionals in obtaining improved clinical outcomes by using cutting-edge biomedical and software engineering methods to automate and streamline patient monitoring regardless of the location. Wireless patient monitoring systems save time and money for the medical personnel while benefiting the patients.
Hari believes that India’s healthcare industry has grown to become one of the country’s most important economic sectors. He says that the expanding reach of the industry’s coverage and services as well as the rising levels of spending by both the public and private sectors are driving the rapid expansion of the sector.

“We want the LifeSigns dashboard to be capable of integrating data from all medical devices in a single location”
Hari Subramaniam, Co-Founder and CEO, LifeSigns

Sharing his thoughts on the immense potential Hari said, “India has long been the “apple of the eye” for investors due to its vast population, unique topography, mixed cultures, and immense potential. With the introduction of the COVID-19 pandemic, India realized the disadvantage it had placed itself in by not prioritizing healthcare, as the virus revealed the country’s inability to combat and overcome new infections. With multiple reasons in its favor, India has the potential to become a healthcare powerhouse. It simply has to make the appropriate moves in the right direction to become a dominant force in this industry.”
Work in progress
Since its inception in 2020, the company has deployed over 20,000 biosensors in over 40 hospitals across India, most notably at Kauvery Chennai, Medanta Gurgaon, Aster Group, and one of the largest and most well-known hospital chains. During the most recent three-month period, LifeSigns has worked on various pilot projects with both private and public hospitals. The conversion period will be longer as a result of the many processes involved in pilot projects. These phases include training workers and putting out software.
“The hospital administrations are highly interested in forming partnerships with us as soon as permission is granted, and the advantages of our biosensor are demonstrated in action via a pilot program. LifeSigns has partnered with Apollo hospitals and the Kauvery chain of hospitals. We have deployed in Medanta, ESI, the railway services in the South, and government hospitals in Tamil Nadu, Assam, and Haryana,” informs Hari.
Sharing details on company’s financial performance, Hari says: “Our total revenue was around Rs 6 crore in the previous year. As the revenue in the latest quarter stood at Rs 4 crores, and the numbers for the next quarter are expected to be twice as high, we anticipate five times revenue this year.”
When asked about the funding, Hari remarked: “The journey from having an idea to having a company that generates income is gratifying, but it requires capital. The first investment method that we picked for LifeSigns was bootstrapping, but as the business has grown, we have realized that we will need to engage in some kind of fundraising.”
Setting the bar high
The company has smallest compactor used in patient monitoring systems, and it further plans to reduce the size along with adding more parameters. It is also focusing on pathological diagnosis and covering the diagnostic space in order to make sure that all information is accessible to physicians at all times and is not constrained by the bounds of any one location.
The primary objective of the company is to become the biggest data supplier at a medical centre. It wants to develop a dashboard application that can be deployed anywhere, whether it be, a primary health care center and even a top-tier hospital.
“We want the LifeSigns dashboard to be capable of integrating data from all medical devices in a single location. Our ultimate objective is to create a platform where anything and all information may be linked for quick access by physicians. If all data were centralised, precise predictions and forecasts could be made in a timely manner, allowing us to save more lives,” Hari signs off.

**This story was first published in ‘November 2022 edition’ of BioVoice eMagazine.